PUNAM GOPAL: Open Payments
NPI 1780187716 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 28 payments from 12 companies in 2025. Trend: 2023 $2,201 · 2024 $1,821 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $307 |
| Madrigal Pharmaceuticals | 2 | $133 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Ardelyx, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $35 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: REZDIFFRA, CREON, LINZESS, RINVOQ, DUPIXENT, IBSRELA, TREMFYA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
